Surface Oncology Inc is a clinical-stage immuno-oncology company. It is developing new therapies that modify the spaces in and around tumors the tumor microenvironment to create conditions that support and sustain anti-tumor immune responses.
$7.94 -0.24 (-2.88%)
As of 04/09/2021 15:59:25 EST IEX book CBOE book
2021 © Stock Market MBA, Inc.